SCHEMBL730750

SCHEMBL730750

O=C(O)c1ccccc1C1CCOCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.49
ALDH1A1 P00352 3/20 0.45
ALOX15 P16050 1/20 0.45
KAT2B Q92831 1/20 0.41
BAZ2B Q9UIF8 1/20 0.41
MLYCD O95822 1/20 0.41
PDE10A Q9Y233 1/20 0.40
KDM4E B2RXH2 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
HMGB1 P09429 1/20 0.39
HPGD P15428 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA7 P43166 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA9 Q16790 1/20 0.39
NAPRT Q6XQN6 1/20 0.39
CA14 Q9ULX7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14717465 0.90 CYP2C9 (0.46) CYP2C9ALDH1A1ALOX15KAT2BBAZ2B
SCHEMBL30175300 0.87 ALDH1A1 (0.54) CYP2C9ALDH1A1ALOX15MLYCDKDM4E
SCHEMBL4109572 0.87 ALDH1A1 (0.54) CYP2C9ALDH1A1ALOX15MLYCDKDM4E
SCHEMBL10457353 0.87 ALDH1A1 (0.54) CYP2C9ALDH1A1ALOX15MLYCDKDM4E
Hydrochloric Acid SCHEMBL29705669 0.85 ALDH1A1 (0.52) CYP2C9ALDH1A1ALOX15MLYCDKDM4E
SCHEMBL364173 0.84 ADRA1A (0.46) CYP2C9ALDH1A1KAT2BBAZ2BPDE10A
SCHEMBL18197670 0.84 KAT2B (0.43) ALDH1A1ALOX15KAT2BBAZ2BPDE10A
SCHEMBL16846514 0.84 KAT2B (0.40) ALDH1A1KAT2BBAZ2BPDE10A
SCHEMBL2731512 0.83 ALDH1A1 (0.50) CYP2C9ALDH1A1ALOX15MLYCDKDM4E
SCHEMBL3634253 0.83 ALDH1A1 (0.50) CYP2C9ALDH1A1ALOX15MLYCDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130190502-A1 ACYLATION REACTION OF HYDROXYL GROUP TAKASAGO INTERNATIONAL CORPORATION (JP) 2013-07-25 US disclosed
US-8431709-B2 Acylation reaction of hydroxyl group TAKASAGO INTERNATIONAL CORPORATION (JP) 2013-04-30 US disclosed
EP-2179007-B1 ALKALOID MONOMERS, LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM DU PONT (US) 2012-10-17 EP disclosed
US-8137582-B2 Alkaloid monomers, liquid crystal compositions and polymer networks derived therefrom E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-03-20 US disclosed
US-20110193019-A1 ALKALOID MONOMERS, LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-08-11 US disclosed
US-20100249422-A1 ACYLATION REACTION OF HYDROXYL GROUP TAKASAGO INTERNATIONAL CORPORATION (JP) 2010-09-30 US disclosed
EP-2196451-A1 ACYLATION REACTION OF HYDROXYL GROUP Takasago International Corporation (JP) 2010-06-16 EP disclosed
EP-2179007-A1 ALKALOID MONOMERS, LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM E. I. du Pont de Nemours and Company (US) 2010-04-28 EP disclosed
WO-2009023762-A1 ALKALOID MONOMERS, LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-02-19 WO disclosed
EP-1976511-A2 FLUORINATED ARYLAMIDE DERIVATIVES Merck & Co., Inc. (US) 2008-10-08 EP disclosed
EP-1973405-A2 HYDROXYALKYLARYLAMIDE DERIVATIVES Merck & Co., Inc. (US) 2008-10-01 EP disclosed
WO-2007087130-A2 HYDROXYALKYLARYLAMIDE DERIVATIVES MERCK & CO., INC. (US) 2007-08-02 WO disclosed
WO-2007087129-A2 FLUORINATED ARYLAMIDE DERIVATIVES MERCK & CO., INC. (US) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110193019-A1 ALKALOID MONOMERS, LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM BHMT, BHMT2, NOTUM CYP2C9 2958/4885ALDH1A1 4396/4885ALOX15 964/4885
US-20130190502-A1 ACYLATION REACTION OF HYDROXYL GROUP ADH5, ADH1A, ACADM CYP2C9 275/4885ALDH1A1 100/4885ALOX15 193/4885
US-20100249422-A1 ACYLATION REACTION OF HYDROXYL GROUP ADH5, ADH1A, ACADM CYP2C9 275/4885ALDH1A1 100/4885ALOX15 193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.